2024 Nobel Prize in Physiology or Medicine — Ambros and Love, Unveiling a New Layer of Gene Regulation with MicroRNA

What You Will Learn in This Article

The 2024 Nobel Prize in Physiology or Medicine was awarded to two researchers who discovered a completely new layer of gene expression regulation. Victor Ambros of the University of Massachusetts Medical School, in 1993, identified that a gene called lin-4 in the nematode C. elegans encodes a short RNA molecule of 21 nucleotides that binds to the mRNA of another gene, inhibiting its translation. Subsequently, Gary Love at Harvard Medical School/Massachusetts General Hospital, in 2000, discovered another short RNA called let-7. He confirmed that this RNA is evolutionarily conserved from yeast, fruit flies, fish, and humans. These two discoveries established the existence of a new regulatory layer called microRNA (miRNA), and it was revealed that there are hundreds to thousands of miRNA genes in the human genome. This layer is involved in the fine-tuning of development, cancer, cardiovascular, neurological, and immune processes, and today, miRNA-based diagnostics and therapeutics are being developed for clinical application.

Beyond Common Knowledge: Gene Expression Has a Fine-Tuning Layer

The common understanding that "genes are either on or off" is a binary switch analogy. In reality, cells regulate gene expression with continuous intensity, and this fine-tuning of intensity determines cellular identity and the precision of development. Until the late 20th century, the molecular basis of this fine-tuning remained largely unknown, and the discoveries of Ambros and Love solved a significant portion of this mystery.

MicroRNAs are fine-tuning regulators of gene expression. These short RNA molecules (approximately 22 nucleotides) are produced within cells and bind to target mRNAs with complementary sequences, leading to either translational repression or degradation of the mRNA. A single miRNA can regulate dozens to hundreds of target mRNAs, and conversely, a single mRNA can be regulated by multiple miRNAs. This is a mesh-like fine-tuning layer superimposed on the network layer of gene expression.

If we frame this in a computational context, it is a dimmer switch for expression intensity. While transcriptional regulation, which turns genes on and off, is an on/off switch, miRNAs are dimmers that precisely control the expression intensity of each gene. This tuning layer allows cells to maintain accurate expression profiles. The acquisition of specific cell identities during development, the stability of cell states in adult tissues, and precise responses to stress all occur within this fine-tuning layer.

The Zeitgeist: December 3rd Martial Law and Impeachment, the Year of the AI Nobel Prize

In 2024, South Korea concluded the year with an unprecedented event in its constitutional history. On the night of December 3rd, President Yoon Suk-yeol declared martial law, and within hours, the National Assembly passed a resolution to lift the martial law, ending it after only six hours. Subsequently, on December 14th, the National Assembly passed an impeachment motion against the President, and the Constitutional Court began its review process. This was the second presidential impeachment in the 21st century, and the very event of martial law was historically unusual. Large-scale demonstrations continued in Gwanghwamun and Yeouido, and international media highlighted both the crisis and resilience of Korean democracy.

Globally, on November 5th, Donald Trump was re-elected as President of the United States. There had been the summer resignation of President Biden and the nomination of Vice President Kamala Harris as his replacement, but ultimately, Trump won. His second term was scheduled to begin on January 20 of the following year, marking a significant variable in global politics.

In September, an Israeli operation involving the mass detonation of Hezbollah pagers and walkie-talkies eliminated a significant portion of the Hezbollah leadership, followed by a full-scale Israeli offensive against Hezbollah. The Middle Eastern landscape was rapidly reshaped, with both Hamas and Hezbollah significantly weakened.

The Paris Olympics, held in July and August, marked the city's centennial hosting of the games. The opening ceremony was held on the Seine, featuring a groundbreaking format, and South Korea achieved good results in archery, taekwondo, and other sports.

In the technology world, in June, NVIDIA surpassed Apple and Microsoft in market capitalization, becoming the world's most valuable company. This trend was driven by a surge in demand for GPUs due to the explosive growth of generative AI. It was a moment when the market reaffirmed that AI had firmly established itself as the defining technology of the 21st century.

In the scientific community, both the Nobel Prize in Physics (John Hopfield and Geoffrey Hinton, contributions to artificial neural networks) and the Nobel Prize in Chemistry (David Baker, Demis Hassabis, and John Jumper, AlphaFold and protein design) were awarded for AI-related achievements, leading to the moniker "the year of the AI Nobel Prize." The simultaneous recognition of contributions to artificial intelligence by the two pillars of natural science was a significant symbol of the late 21st century. Amid this trend, the Nobel Prize in Physiology or Medicine acknowledged the foundational discoveries in RNA biology, reaffirming the enduring power of natural biology.

Personal Narratives: Two Graduate Students in Hobert's Lab

Victor Ambros (born 1953) was born in New Hampshire, USA. He received his Bachelor's and Ph.D. from the Massachusetts Institute of Technology (MIT). The laboratory where he was trained was that of H. Robert Horvitz, the 2002 Nobel Laureate in Physiology or Medicine for his discovery of programmed cell death. Ambros's graduate years were dedicated to studying the developmental genetics of C. elegans.

Gary Love (born 1952) was born in California, USA. He received his Bachelor's degree from Harvey Mudd College and his Ph.D. from Harvard University. He was also a graduate student in Hobert's laboratory and was there at the same time as Ambros. The fact that the two met in the same laboratory marked the beginning of 30 years of collaboration and competition.

The problem that both were interested in was the temporal regulation of development in C. elegans. The transitions between developmental stages in the worm's embryo occur at precise times, and the genes that control these timing points were known to be lin-4 and lin-14. Genetic observations suggested that lin-14 expression must be downregulated for the next developmental stage to proceed, and that lin-4 plays a role in repressing this lin-14 expression, but the molecular relationship between the two genes was a mystery.

The decisive turning point came in 1993. The Ambros team cloned the lin-4 gene and discovered that it does not encode a protein. Instead, this gene produces a short RNA molecule of 21 nucleotides, and the sequence of this short RNA is complementary to a specific region in the 3' UTR of lin-14 mRNA. In other words, the short RNA produced by lin-4 binds to lin-14 mRNA, a completely new mechanism of gene regulation that represses its translation.

The Love team, in the same paper (1993, Cell special issue), genetically confirmed that the 3' UTR of lin-14 mRNA is indeed the critical site for this regulation. The two discoveries completed the picture, and while groundbreaking, it was initially considered a "peculiar phenomenon specific to C. elegans." Most of the scientific community interpreted this discovery as a worm-specific phenomenon that would not generalize to other organisms.

In 2000, a key discovery by the Love team fundamentally changed this picture. They discovered a second miRNA, let-7, and, surprisingly, the sequence of this let-7 was evolutionarily conserved in fruit flies, fish, and humans. This strongly suggested that miRNAs are not worm-specific phenomena but are a fundamental regulatory system present throughout eukaryotes.

In the years that followed, hundreds of miRNAs were discovered in various organisms, including humans, and it was confirmed that there are approximately 1,000 to 2,000 miRNA genes in the human genome. It was also revealed that more than 60% of human protein-coding genes are regulated by miRNAs in some way. The worm experiment of the two graduate students had established a fundamental layer of gene expression regulation.

The Nobel Prize arrived 30 years later, in 2024. In the intervening years, the field of miRNA has grown explosively, with significant increases in the number of academic publications, clinical applications, and industrial investment.

Key Achievements: The Fine-Tuning Layer of Expression Regulation in a Computational Framework

If you were to draw a pipeline of miRNA generation and function, it would look like this:

• Transcription: The miRNA gene is transcribed by RNA polymerase II to produce a long pri-miRNA transcript.
• Nuclear Cleavage: The Drosha-DGCR8 complex cleaves the pri-miRNA to create a hairpin-shaped pre-miRNA.
• Cytoplasmic Transport: Exportin-5 transports the pre-miRNA to the cytoplasm.
• Cytoplasmic Cleavage: Dicer cleaves the pre-miRNA to produce a mature miRNA double-strand of 21-22 nucleotides.
• RISC Loading: One strand of the double-strand is loaded into the RISC (RNA-induced silencing complex), and the other strand is discarded.
• Target Recognition: The loaded miRNA-RISC complex searches for its target mRNA. The seed sequence (2-8 nucleotides) of the miRNA binds complementarily to the 3' UTR of the target mRNA.
• Translational Repression or Degradation: After binding, the mRNA's translation is repressed, or the mRNA is degraded. The exact outcome (repression vs. degradation) depends on the degree of complementarity and cellular conditions.

The identity of this system is fine-tuning regulation at the post-transcriptional level. While transcriptional regulation is a binary switch that turns genes on and off, miRNAs are dimmers that precisely control the expression intensity of each gene. The mesh-like regulatory network in which one miRNA regulates multiple targets and one target is regulated by multiple miRNAs is characteristic of this layer.

The relationship to RNAi reveals the evolutionary background of this system. The 2006 Nobel Prize (Fire and Mello) was awarded for the RNA interference system—Dicer, RISC, Argonaute—which is also used in the miRNA system. In fact, cells use this single infrastructure for two purposes: internal regulation (miRNA) and external defense (RNAi, response to viral dsRNA). The two systems share components but differ slightly in their purpose and mode of operation.

The mesh of target specificity creates the computational complexity of this system. Because the seed sequence of miRNA is short (6-8 nucleotides), a single miRNA can match hundreds of target mRNAs. In reality, how much a particular target is regulated depends on the binding strength, cellular conditions, and interactions with other factors. Within this mesh, the cell maintains its precise expression profile.

It is also important to acknowledge the limitations of this analogy. miRNA regulation is mostly a weak repression, not a strong silencing. In many cases, each miRNA does not completely eliminate its target mRNA but rather reduces its expression by 20-50%. This subtle regulation may not be significant on its own, but when dozens or hundreds of miRNAs act together, they can create a fundamental change in cell state. This is similar to how the last few percent of improvement in software optimization can have a decisive impact on the overall system performance.

Why It Matters: Development, Cancer, Diagnostics, and Precision Medicine

First, understanding the regulation of development. miRNAs are key in the precise timing and intensity control of embryonic development and tissue-specific differentiation. Let-7 is low in the early stages of development and increases in the later stages, acting as a switch that determines the developmental state of cells. Specific miRNA profiles appear at each stage of heart, muscle, and nerve development, and these profiles serve as decisive markers of cell identity.

Second, understanding and diagnosing cancer. In many tumors, miRNA expression differs significantly from that of normal cells. Certain miRNAs (e.g., miR-21) are overexpressed in many cancers and function like oncogenes, while other miRNAs (e.g., let-7, miR-15/16) act as tumor suppressor miRNAs. These miRNA profiles are being developed as biomarkers for cancer diagnosis, prognosis prediction, and prediction of treatment response, and several commercial miRNA diagnostic kits have been introduced into clinical practice.

Third, the stability of blood miRNAs creates amazing diagnostic opportunities. miRNAs are present quite stably in the blood and are detected as circulating miRNAs. This offers the potential to detect the state of tumors, cardiovascular diseases, and liver diseases with just a blood test, without the need for tissue biopsies. Several blood-based early cancer diagnosis kits are being developed using miRNA profiles.

Fourth, clinical entry of miRNA-based therapeutics. Several clinical trials are underway with anti-miRNAs that target specific miRNAs or miRNA mimics that supply the miRNAs themselves. An inhibitor of miR-122 (miravirsen) showed early clinical success in hepatitis C, and several developments are underway in cardiovascular, cancer, and liver diseases.

Fifth, new approaches to cardiovascular and neurological diseases. miRNAs have been shown to be involved in the pathology of heart regeneration, recovery after stroke, and neurodegenerative diseases, and are becoming new therapeutic targets for these diseases.

Sixth, evolutionary insights. The miRNA system has existed since very early in the evolution of eukaryotes and operates on fundamentally similar principles in worms, flies, and humans. Let-7 is highly conserved, with its sequence almost identical from the nematode to humans, indicating that this system is a fundamental component of the evolution of multicellular eukaryotes. Although we and worms diverged 600 million years ago, the fundamental components of expression regulation have not fundamentally changed over that long period.

Seventh, a re-evaluation of the RNA world. Genetics in the late 20th century emphasized a protein-centric view, but discoveries in the early 21st century – RNAi (2006), miRNAs (2024), and mRNA vaccines (2023) – have repeatedly confirmed that the RNA world is a crucial axis of gene expression, regulation, and therapy. A new understanding has emerged of how important a regulatory role non-coding RNAs play in the genome, and it has been revealed that a significant portion of the human genome is used to create these regulatory RNAs.

Eighth, the 30-year story from graduate student discoveries to the Nobel Prize. The story of how the worm experiment, which began with two graduate students meeting in Hobert's lab, was established 30 years later as a fundamental layer of gene expression regulation is a prime example of the long-term nature of basic research and its ultimate impact. It was also a moment when the tiny worm, C. elegans, was recognized once again on the stage of the Nobel Prize (the second time after Brenner, Hobert, and Sulston in 2002).

A short RNA fragment precisely regulates gene expression. This insight opened a new dimension in 21st-century genetics, and the twenty-fourth Nobel Prize in Physiology or Medicine of the new century was awarded to the two pioneers of this insight. The story, which began with the regulation of development in worms, has now confirmed a major trend in which it has become a new tool for the diagnosis and treatment of human diseases.

→ Previous: 2023 Nobel Prize in Physiology or Medicine → Next: 2025 Nobel Prize in Physiology or Medicine